CD36 and pulmonary fibrosis: One molecule that holds promise as a therapeutic target in pulmonary fibrosis is CD36 as several complimentary animal models of pulmonary fibrosis reveal that targeted deletion of the CD36 gene leads to protection against scarring [6, 7].